Home  /  Podcast Directory  /  Science  /  International Stem Cell Corporation


Last update: 0000-00-00

The Ellis Martin Report: Interview with International Stem Cell Corporation’s Founder/Co-Chairman

0000-00-00
Length: 5s

TEMR: Welcome to The Ellis Martin Report.  I’m Bob Lange.  We’re talking with Kenneth Aldrich, Executive Chairman of International Stem Cell Corporation, trading on the OTC Market with the symbol ISCO.   International Stem Cell Corporation has bee…

x

Share: The Ellis Martin Report: Interview with International Stem Cell Corporation’s Founder/Co-Chairman


The Ellis Martin Report: Interview with Ken Aldrich of International Stem Cell Corp.

0000-00-00

Ken Aldrich of International Stem Cell Corp (ISCO.OB) on the Present and Future of Stem Cell Research and Applications The Ellis Martin Report: International Stem Cell Corporation trades under the symbol ISCO.OB on the Over the Counter Bulletin Board an…

x

Share: The Ellis Martin Report: Interview with Ken Aldrich of International Stem Cell Corp.


ISCO and Absorption Sytems to Commercialize Stem Cell Derived Human Corneal Tissue for Drug Test

0000-00-00
Length: 3s

International Stem Cell Corporation (OTCBB:ISCO (www.internationalstemcell.com), the first company to perfect a method of creating human “parthenogenetic” stem cells from unfertilized eggs, has formed a partnership with…

x

Share: ISCO and Absorption Sytems to Commercialize Stem Cell Derived Human Corneal Tissue for Drug Test


International Stem Cell Corporation Announces a Manufacturing and Supply Agreement with Millipore Co

0000-00-00

International Stem Cell (OTCBB:ISCO) announced today it has entered into a worldwide distribution agreement with Millipore Corporation (NYSE: MIL) to manufacture living cells and cell culture products to be sold through Millipore’s distribution network…

x

Share: International Stem Cell Corporation Announces a Manufacturing and Supply Agreement with Millipore Co


International Stem Cell Corporation Arranges $3 Million Equity Financing

0000-00-00
Length: 2s

OCEANSIDE, Calif.–(BUSINESS WIRE)–International Stem Cell Corporation (OTCBB: ISCO - News) has entered into a subscription agreement with an accredited investor to sell three million dollars ($3,000,000) of Series C Preferred St…

x

Share: International Stem Cell Corporation Arranges $3 Million Equity Financing


A Frank Discussion About Stem Cell Research with International Stem Cell CEO

0000-00-00
Length: 4s

Ken Aldrich, CEO of International Stem Cell Corporation, addresses some timely issues regarding stem cell research. To learn more about ISCO or to contact them regarding further questions, please visit their website here …

x

Share: A Frank Discussion About Stem Cell Research with International Stem Cell CEO


Meet Ken Aldrich the co-founder of International Stem Cell Corporation

0000-00-00
Length: 4s

Welcome to this podcast. I am Ken Aldrich, Chairman and co-founder of International Stem Cell Corporation. International Stem Cell Corporation recently announced that our scientific team, led by our Chief Scientist, Dr. Elena Revazova, has created a new …

x

Share: Meet Ken Aldrich the co-founder of International Stem Cell Corporation


International Stem Cell Corporation

is a biotechnology company developing therapeutic and research products through the use of human stem cells.

International Stem Cell Corporation


Switch to our mobile site